Landscapes / Companies
Telix Pharmaceuticals (Innovations) Pty Limited not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
7
in active trials · 8 in all
Trials
9 active
13 since 2021
Drugs7
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Approved | Jan 2027Phase 3 trial completes | |||
| Next date | Jan 2027 · Phase 3 trial completes | ||||
| Also tested for | PCA, Prostate Cancer and 7 more | ||||
| Open drug page | |||||
— |
Phase 3 | Dec 2027Phase 3 trial completes | |||
| Next date | Dec 2027 · Phase 3 trial completes | ||||
| Also tested for | Metastatic Castration-resistant Prostate Cancer | ||||
| Open drug page | |||||
Floretyrosine Fnot checked |
— |
Phase 3 | Apr 2028Phase 3 trial completes | ||
| Next date | Apr 2028 · Phase 3 trial completes | ||||
| Also tested for | Brain Metastasis, Radiation Necrosis and 2 more | ||||
| Open drug page | |||||
— |
Phase 3 | Jul 2028Phase 3 trial completes | |||
| Next date | Jul 2028 · Phase 3 trial completes | ||||
| Also tested for | Neoplastic Disease, Glioblastoma and 5 more | ||||
| Open drug page | |||||
89Zr-Girentuximabnot checked |
— |
Phase 3 | — | ||
| Also tested for | Clear Cell Renal Cell Carcinoma | ||||
| Open drug page | |||||
— |
Phase 2 | 31 Dec 2028Phase 2 trial completes | |||
| Next date | 31 Dec 2028 · Phase 2 trial completes | ||||
| Also tested for | Solid Tumor, Adult, Advanced Solid Tumor and 7 more | ||||
| Open drug page | |||||
— |
Phase 1 | 26 Apr 2027Phase 1 trial completes | |||
| Next date | 26 Apr 2027 · Phase 1 trial completes | ||||
| Also tested for | Bone Pain, Metastatic Bone Tumor and 1 more | ||||
| Open drug page | |||||
About
- No active trial
- 177Lu-DOTA-TLX591
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021